** Shares of AFT Pharmaceuticals Ltd AFT.NZ soar as much
as 12.5% to NZ$3.61, hits highest level since April 29
** The drugmaker posts full-year net profit of NZ$19.8 mln
($12.70 mln) compared to NZ$7.8 million reported last year
urn:newsml:reuters.com:*:nNZW4zFRLf
** Announces board's intention to pay a dividend (in
relation to FY23) in the range of 20-30% range of normalized net
profit after tax
** Stock marks best session since April 28, if gains hold
** Stock has fallen 28.4% this year, as of last close
($1 = 1.5586 New Zealand dollars)
(Reporting by Jaskiran Singh in Bengaluru; Editing by Daniel
Wallis)
((Jaskiran.Singh@thomsonreuters.com;))